Volpara Health TechnologiesのEPS 1株当たり利益
Volpara Health TechnologiesのEPS 1株当たり利益 は何ですか。
Volpara Health Technologies LimitedのEPS 1株当たり利益 は-0.06です。
EPS 1株当たり利益 の定義は何ですか。
1株当たり利益（EPS) は、当社の1株当たり利益です。それは株式の希釈を考慮に入れ、 過去12ヶ月間にカウントされます。
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
ASXのセクタHealth CareにおけるEPS 1株当たり利益 の企業と比べるVolpara Health Technologies
Volpara Health Technologiesは何をしますか。
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Volpara Health Technologiesと類似のeps 1株当たり利益
- Greenpro CapitalのEPS 1株当たり利益 は-0.06です。
- KilliのEPS 1株当たり利益 は-0.06です。
- 10284のEPS 1株当たり利益 は-0.06です。
- UnitedのEPS 1株当たり利益 は-0.06です。
- China Digital VideoのEPS 1株当たり利益 は-0.06です。
- Yashili International LtdのEPS 1株当たり利益 は-0.06です。
- Volpara Health TechnologiesのEPS 1株当たり利益 は-0.06です。
- Denox Environmental & TechnologyのEPS 1株当たり利益 は-0.06です。
- BuruのEPS 1株当たり利益 は-0.06です。
- Greenpro CapitalのEPS 1株当たり利益 は-0.06です。
- HanveyのEPS 1株当たり利益 は-0.06です。
- Huntsman Exploration IncのEPS 1株当たり利益 は-0.06です。
- Armada Metals LtdのEPS 1株当たり利益 は-0.06です。